Newcells Biotech Overview
- Founded
- 2014

- Status
- Private
- Employees
- 27

- Latest Deal Type
- Later Stage VC
- Latest Deal Amount
- $7.24M

- Investors
- 3
Newcells Biotech General Information
Description
Developer of a biotechnology platform designed to produce induced pluripotent stem cells. The company's platform is at the forefront of the production and differentiation of human-induced pluripotent stem cells (hiPSC), which is quickly advancing the field of pre-clinical disease modeling and drug safety evaluation, enabling researchers to research and test new drugs and screen potential drug molecules for efficacy and toxicity.
Contact Information
- The Biosphere Drayman's Way
- Newcastle Helix
- Newcastle Upon Tyne NE4 5BX
- England, United Kingdom
Newcells Biotech Timeline
Newcells Biotech Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Later Stage VC | 23-Feb-2021 | $7.24M | 000.00 | 000.00 | Completed | Generating Revenue |
4. Early Stage VC | 000 | 00.00 | Completed | Generating Revenue | ||
3. Early Stage VC | 04-Jul-2018 | 00.000 | 00.000 | 00.000 | Completed | Generating Revenue |
2. Grant | 10-Oct-2016 | $239K | Completed | Generating Revenue | ||
1. Seed Round | 02-Sep-2015 | $239K | $239K | 00.000 | Completed | Generating Revenue |
Newcells Biotech Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
F2 Ordinary | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
F1 Ordinary | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
E Ordinary | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
F2 Ordinary | 00,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.00 | |
F1 Ordinary | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
E Ordinary | 00,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
D2 Ordinary | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
D1 Ordinary | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
C Ordinary | 337,969 | $0.000138 | $2.04 | $2.04 | 1x | $2.04 | 6.67% | |
Ordinary A | 29,500 | $0.000138 | $7.18 | $7.18 | 1x | $7.18 | 0.58% |
Newcells Biotech Comparisons
Industry
00000000
000 0000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialNewcells Biotech Competitors (24)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
DefiniGEN | Venture Capital-Backed | Cambridge, United Kingdom | 00 | 000.00 | 0000000000 0 | 000.00 |
000 0000000000000 | Venture Capital-Backed | Seattle, WA | 00 | 000.00 | 0000000000 | 000.00 |
0000000 0000000000 | Venture Capital-Backed | South San Francisco, CA | 00 | 000.00 | 00000000000 | 000.00 |
0000 00000000000 | Private Equity-Backed | Cambridgeshire, United Kingdom | 00 | 00.000 | 0000000 0000 | 00.000 |
00000000 | Venture Capital-Backed | South San Francisco, CA | 00 | 00000 | 0000000000 | 00000 |
Newcells Biotech Executive Team (3)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Michael Nicholds | Chief Executive Officer & Board Member | ||
Lyle Armstrong Ph.D | Chief Scientific Officer & Board Member | ||
Majlinda Lako Ph.D | Founder |
Newcells Biotech Board Members (5)
Name | Representing | Role | Since |
---|---|---|---|
Frank Armstrong MD | Self | Board Member | 000 0000 |
Lyle Armstrong Ph.D | Newcells Biotech | Chief Scientific Officer & Board Member | 000 0000 |
Michael Nicholds | Newcells Biotech | Chief Executive Officer & Board Member | 000 0000 |
Sandy Primrose | Self | Chairman | 000 0000 |
Timothy Levett | NVM Private Equity | Board Member | 000 0000 |
Newcells Biotech Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialNewcells Biotech Investors (3)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Mercia Asset Management | Venture Capital | Minority | 000 0000 | 000000 0 | |
NVM Private Equity | PE/Buyout | Minority | 000 0000 | 000000 0 | |
Northstar Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |